Skip to main content
Filing year 2024

ALS THERAPY DEVELOPMENT FOUNDATION INC

Watertown, Massachusetts·EIN 04-3462719·NTEE H80 · Medical Research·3
Total revenue
$13.4M
Total assets
$23.1M
Total expenses
$0
Reported officers
23
Mission

OUR MISSION IS TO IDENTIFY VIABLE TARGETS FOR THERAPY DEVELOPMENT AND EXPEDITIOUSLY MANAGE THE CREATION OF THOSE TREATMENTS THAT WILL ARREST THE SUFFERING OF TODAY'S ALS PATIENTS.

Executive compensation, broken down

Form 990 · Schedule J · 6 reported individuals · Filing year 2024

Base salaryBonusOther compensationBenefits
Base salaryBonusOther compensationBenefitsExecutive compensation
$415k
VP of Research
vice president
$209k
VP of Development
vice president
$187k
Director, Cell Biology
highest compensated employee
$185k
Director of Pharmacology
highest compensated employee
$170k
Senior Director of Marketing & Communications
director (operational)
$156k

Plus 17 unpaid individuals.

Browse compensation in Medical Research

Up 22%
from 2023

From $340k in 2023 to $415k in 2024.

$340k
2023
$415k
2024
Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.